✦ LIBER ✦

The Prognostic Significance of p16 in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab, and IMRT

✍ Scribed by Lau, K.; Tong, C.C.L.; Rivera, M.; Packer, S.H.; Cannan, D.; Teng, M.S.; Sikora, A.G.; Gupta, V.; Genden, E.M.; Kao, J.

Book ID: 123429435
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.780

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of p16 expression in head a

Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab

✍ Heiduschka, Gregor; Grah, Anja; Oberndorfer, Felicitas; Seemann, Rudolf; Kranz, 📂 Article 📅 2014 🏛 Springer 🌐 German ⚖ 336 KB

Prognostic significance of p16 in locall

Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy

✍ Harold Y. Lau; Sony Brar; Alexander C. Klimowicz; Stephanie K. Petrillo; Desirée 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 2 views

## Abstract ## Background Human papillomavirus (HPV)–related squamous cell cancer of the head and neck (SCCHN) has emerged as a distinct clinical entity. The expression of p16 protein can be used as a surrogate for HPV status. ## Methods p16 immunohistochemistry (IHC) was assessed in archival pa

Efficacy of concurrent cetuximab vs. 5-f

Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

✍ Shapiro, Lauren Q.; Sherman, Eric J.; Riaz, Nadeem; Setton, Jeremy; Koutcher, La 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Competing causes of death in patients wi

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

✍ Jaime Gómez-Millán, Maria Dolores Toledo… 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 237 KB

Poster 037: Concurrent Chemoradiotherapy

Poster 037: Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (TPF) in Patients With Advanced Head and Neck Cancer

✍ Shinsuke Ohta 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we